Thursday, 18 Jan 2018

You are here

Lyrica Fails in Sciatica Pain

Lyrica (pregabalin) was first approved in 2004 and since has been studied and approved for use in neuropathic pain (associated with diabetic neuropathy), postherpetic neuralgia, partial onset seizures, fibromyalgia and neuropathic pain with spinal cord injury. It is often used to manage chronic pain and neuropathic pain outside these indications.

Australian investigators published their findings in the NEJM last week showing that pregabalin was no better than placebo in treating leg pain associated with sciatics (acute or chronic). 

Patients (n=209) were randomized to either pregabalin at a dose of 150 mg per day (max adjusted to 600 mg per day) or placebo for 8 weeks. The primary outcome was the leg-pain using a 10-point scale at weeks 8 and 52. They also examined disability, back-pain intensity, and quality-of-life measures. Secondary measures demonstrated the same lack of effect.

There were 227 adverse events in the pregabalin group and 124 in the placebo group. Dizziness was more common in the pregabalin group than in the placebo group.

Pregabalin did not sufficiently reduce the leg pain of sciatica, short term or long term and was associated with a higher adverse event rate. 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Cannibis Weakly Effective in Neuropathic Pain

The medical use of cannabis is often extended to management of chronic pain and neuropathic pain.

A metanalysis of 27 chronic pain trials show that there is low-strength evidence that cannabis alleviates neuropathic pain but insufficient evidence in other pain populations.

However, there was little evidence that cannabis can alleviate pain associated with multiple sclerosis, cancer, or rheumatic conditions.  

AASM Guidelines for Sleep Apnea Testing

A task force from the American Academy of Sleep Medicine (AASM) performed a systematic review of the scientific literature on obstructive sleep apnea and screening tests.

Fibromyalgia Diagnosed by Two Simple Tests

Researchers from the Oregon Health Science Center have reported that fibromyalgia can be distinguished from chronic pain by primary care providers (PCPs) who employ two simple screening tests: BP cuff-evoked pain and a single patient question, and pain induced by pinching the Achilles tendon. 

Opioid Crisis Costs US $500 Billion

Reuters reports that the opioid crisis has cost the United States as much as $504 billion in 2015,  based on a White House economists report released this week. The White House Council of Economic Advisers (CEA) said the toll from the opioid crisis represented 2.8% of gross domestic product that year.

DEA Cracks Down on Illicit Fentanyl

Reuters reports that  U.S. Drug Enforcement Administration (DEA) has declaed it would classify illicit versions of fentanyl at the same level as heroin, allowing criminal prosecution of anyone who possesses, distributes or manufactures illicit versions of the drug.